Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
See Latest ArticlesIdentification of p53 as a strong predictor of survival for patients with malignant peripheral nerve sheath tumors
Neuro-Oncology, 10/06/09
Brekke HR et al. – This is the most comprehensive study of in situ protein expression in MPNST so far, and expressed p53 was found to be a strong surrogate marker for outcome. Patients in complete remission with a primary p53–positive MPNST diagnosis may be considered in a high–risk subgroup and candidates for adjuvant treatment.
Related Articles
Malignant Peripheral Nerve Sheath Tumor of the Renal Pelvis
Urologia Internationalis, 10/22/09
Relevance Score: 81%
Surgical strategies for managing foraminal nerve sheath tumors: the emerging role of CyberKnife ablation
European Spine Journal, 10/13/09
Relevance Score: 81%
Inhibition of Eyes Absent Homolog 4 expression induces malignant peripheral nerve sheath tumor necrosis
Oncogene, 11/12/09
Relevance Score: 80%
Plexiform Fibromyxoma: A Distinctive Benign Gastric Antral Neoplasm Not to be Confused With a Myxoid GIST
American Journal of Surgical Pathology, 10/28/09
Relevance Score: 79%
Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours
The Journal of Pathology, 11/09/09
Relevance Score: 68%
Today in Neurologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Antiepileptics in brain metastases: safety, efficacy and impact on life expectancy
Journal of Neuro-Oncology, 12/04/09
High-dose chemotherapy and autologous stem cell rescue for atypical teratoid/rhabdoid tumor of the central nervous system
Journal of Neuro-Oncology, 12/04/09
Seizure risk in brain tumor patients with conversion to generic levetiracetam
Journal of Neuro-Oncology, 12/04/09
Sponsor
Article Search
Sponsor